Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus Rescue in Chronic Allograft Dysfunction
NCT01046045Phase 4Completed
- Sponsor
- The Chinese University of Hong Kong
- Start
- Apr 2008
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of everolimus in chronic allograft dysfunction (CAD), sponsored by The Chinese University of Hong Kong. Started Apr 2008; status: completed.
02
Drugs
everolimus
03
Conditions
chronic allograft dysfunction (CAD)
Beyond the preview
Go deeper on NCT01046045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01046045.